European Business Schools Librarian's Group
ESSEC Working Papers,
ESSEC Research Center, ESSEC Business School
No DR 07002: Evolution comparée de la consommation de médicaments dans les 5 pays européens entre 2000 et 2004 : analyse de 7 classes pharmaco-thérapeutiques
Gérard Viens (), Karine Levesque, Pierre Chahwakilian, Abdelkader El Hasnaoui, Anne Gaudillat, Guénolé Nicol and Caroline Crouzier
Additional contact information
Gérard Viens: Essec Business School, Postal: Avenue Bernard Hirsch - B.P. 50105, 95021 CERGY-PONTOISE Cedex , FRANCE,
Karine Levesque: Aremis consultants, Postal: 10 rue Beffroy, 92200 NEUILLY-SUR-SEINE, FRANCE,
Pierre Chahwakilian: GlaxoSmithKline, Postal: 100 rte Versailles, 78160 MARLY-LE-ROI , FRANCE
Abdelkader El Hasnaoui: GlaxoSmithKline, Postal: 100 rte Versailles, 78160 MARLY-LE-ROI , FRANCE
Anne Gaudillat: GlaxoSmithKline, Postal: 100 rte Versailles, 78160 MARLY-LE-ROI , FRANCE
Guénolé Nicol: GlaxoSmithKline, Postal: 100 rte Versailles, 78160 MARLY-LE-ROI , FRANCE
Caroline Crouzier: GlaxoSmithKline, Postal: 100 rte Versailles, 78160 MARLY-LE-ROI , FRANCE
Abstract: The drug consumption level in France is often considered as being one of the most important in Europe. This study aims at confirming this assertion over the period 2000-2004 by comparing drug consumption in Germany, Spain, France, Italy and the United-Kingdom. The results show that in 2004 drug consumption in France was no more the biggest for all the seven studied classes. Moreover, the consumption levels of the five countries have converged between 2000 and 2004, as well as the consumption structures.
Keywords: Defined Daily Dose (DDD); Drug Consumption; European Comparative Analysis
JEL-codes: I11
28 pages, February 2007
Full text files
showDeclFileRes.do?declId=6861&key=__workpaper__
Questions (including download problems) about the papers in this series should be directed to Sophie Magnanou ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2024-02-05 15:47:16.